Advisor Group, Inc. - AMPHASTAR PHARMACEUTICALS IN ownership

AMPHASTAR PHARMACEUTICALS IN's ticker is AMPH and the CUSIP is 03209R103. A total of 110 filers reported holding AMPHASTAR PHARMACEUTICALS IN in Q4 2017. The put-call ratio across all filers is - and the average weighting 0.0%.

Quarter-by-quarter ownership
Advisor Group, Inc. ownership history of AMPHASTAR PHARMACEUTICALS IN
ValueSharesWeighting
Q4 2019$17,000
+6.2%
875
+10.1%
0.00%
Q3 2019$16,000
-5.9%
7950.0%0.00%
Q2 2019$17,000
+13.3%
795
+6.0%
0.00%
Q1 2019$15,000
-50.0%
750
-50.0%
0.00%
Q4 2018$30,000
+3.4%
1,5000.0%0.00%
Q3 2018$29,000
-23.7%
1,500
-40.0%
0.00%
-100.0%
Q2 2018$38,000
+26.7%
2,500
+56.2%
0.00%
Q1 2018$30,000
-3.2%
1,6000.0%0.00%
Q4 2017$31,000
+6.9%
1,6000.0%0.00%
Q3 2017$29,000
-14.7%
1,600
-14.2%
0.00%
-100.0%
Q2 2017$34,000
+3300.0%
1,864
+2682.1%
0.00%
Q1 2017$1,000
-88.9%
67
-86.2%
0.00%
Q3 2016$9,0004870.00%
Other shareholders
AMPHASTAR PHARMACEUTICALS IN shareholders Q4 2017
NameSharesValueWeighting ↓
MQS Management LLC 10,935$255,0000.41%
GLOBEFLEX CAPITAL L P 144,692$3,370,0000.34%
CORNERCAP INVESTMENT COUNSEL INC 58,975$1,374,0000.20%
Factorial Partners, LLC 10,900$254,0000.17%
FEDERATED HERMES, INC. 3,464,335$80,684,0000.15%
Campbell & CO Investment Adviser LLC 14,800$345,0000.12%
FULLER & THALER ASSET MANAGEMENT, INC. 611,462$14,241,0000.08%
Summit Global Investments 45,900$1,069,0000.07%
RENAISSANCE GROUP LLC 63,559$1,480,0000.06%
PDT Partners, LLC 33,459$779,0000.06%
View complete list of AMPHASTAR PHARMACEUTICALS IN shareholders